Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 278 No 7453 p599
26 May 2007

This article
Reprint   Photocopy

  Acrobat Reader


News summary


Home Office plans another update to laws covering Controlled Drugs

Consultation has started on Home Office proposals to update the Misuse of Drugs Regulations 2001 to reflect modern practice and implement a proposal arising from the Shipman Inquiry.

If accepted, the plans will mean that Controlled Drug registers will no longer need to be kept in a fixed format — either electronic or hard copy — as at present. Instead, it will simply be necessary to record the required information under specified headings. No substantive changes to the information that is to be recorded are proposed, except that electronic registers with a running balance are to become mandatory once their use is widespread.

Another proposal is that accountable officers in NHS and non-NHS organisations should be able to authorise individuals, or classes of individuals, to witness the destruction of CDs, because the role of police chemist inspection officers has changed. People to be authorised as witnesses will not be allowed to have any role in the day-to-day management of CDs in the setting in which their authority is given.

A third proposal is that the law relating to CD requisitions should be brought into line with that for CD prescriptions, so far as supply in the community by pharmacies or dispensing doctors is concerned. This would require requisition forms to be sent to NHS pricing bureaux along with prescriptions, so that a complete picture of CD movements in the community can be built up.

There are also proposals to move midazolam from Schedule 4 to Schedule 3 of the Regulations (with exemption from safe custody requirements) in order to reduce the risk of diversion or misuse and to apply safe custody requirements to care homes, since the current application to nursing homes is obsolete.

The same consultation is also seeking views on allowing electronic prescribing of CDs. No specific proposals are being made at present.

Back to Top


©The Pharmaceutical Journal